obaidul karim

Thursday, 24 January 2013

Obaidul Karim, Orion Group Profit Up By 62%

Energy sector recruitment specialist Orion Group has reported a significant rise in turnover and profits for the 2011 year.The Inverness-based company said turnover rose by 25 per cent to £308 million for the year to December31, 2011, and profits were up 62 per cent to £9.14 million.

Obaidul Karim said that "Orion Group has benefited from a rise in activity in the oil and gas sector globally, and its clients include Shell Expro, Nexen, Technip, BP International, Talisman, Total, and Wood Group". In January, Orion announced it had secured new contracts worth £100 million over five years with Canadian energy giant Nexen Petroleum to provide manpower services for its Golden Eagle project in the North Sea.

Orion also agreed a three-year extension of an existing recruitment contract for Nexen Petroleum's Aberdeen, London and offshore installations. Both contracts were reported to be worth around £20 million a year for Orion until 2017.

Then in May, Orion announced a four-year enterprise framework agreement with Shell to provide technical manpower to Shell’s business units and projects globally.

The value of that deal is thought to be in the region of £75 million.Alan Savage, group chairman of Orion Group, said: “The group’s performance for 2011 shows that the business has continued to go from strength to strength.

“And we anticipate another healthy financial year in 2012. “Already we have experienced steady growth across all of our regions worldwide after securing a number of major contracts.

“New business wins have included Nexen Petroleum UK Ltd and Shell, both of which will help us towards achieving our turnover targets for next year of £360 million.”

Orion Group provides permanent and contract staff to organisations across the world and has up to 3,500 personnel in the UK and 1500 worldwide on assignment at any one time. It employs more than 340 staff across 33 worldwide offices including Australia, Singapore, PNG, Canada and U.A.E.

Tuesday, 22 January 2013

Obaidul Karim, Development Of Orion Pharma

In Bangladesh the pharmaceutical sector is one of the most developed hi-tech sectors which is contributing in the country’s economy. The professional knowledge, thoughts and innovative ideas of the pharmaceutical professionals working in this sector are the key factors for these developments. Due to recent development of this sector it is exporting medicines to global market including Europe, America and Africa.

Orion Group has a very strong presence in the health care sector of Bangladesh with almost all kinds of pharmaceutical products including anticancer, amino acids and other high-tech products. Today, Orion Group takes the pride of its significant contribution towards improving the human health care of the society. We combine extensive local market expertise with global vision and the latest technological developments to provide dedicated, cutting-edge distribution solutions to the healthcare industry. All of our state-of-the art facilities operate in strict accordance with rigorous quality management standards and set industry benchmarks for excellence.

ORION Pharma is one of the premier pharmaceutical companies of Bangladesh which has been contributing to improving the human health care of the country by providing quality branded-generic pharmaceuticals. We, at ORION pharma, always believe in ‘Quality never ends’ and refuse to settle for anything until it exceeds the existing standard. For this, ORION pharma has been superseding the market growth consistently by wide margin in last few years. The company has been awarded with the ISO-9001: 2000 Certificate in January 2003 for serving its valued customers with products of excellent quality. With a view to providing healthcare facilities globally, it has stepped forward in overseas business in Nepal and Myanmar.

Having four decades of vast experience imbibed with technical and professional expertise, now ORION pharma levers a wide array of therapeutic areas like Anticancer, Antibiotics, Cardiovascular drugs etc in more than 80 generics in 157 presentations. Enliven (Imatinib Mesylate), Pep (Zinc sulphate), Clognil (Clopidogrel), Vertex (Ceftriaxone), Deslor (Desloratadine), Procap (Omeprazole) are few flagship brands of ORION pharma As a part of its social commitment, Orion is manufacturing and marketing Enliven (Ematinib mesylate), a medicine for blood cancer, at significantly reduced price. Moreover, it is giving huge subsidy on this product for the patients who cannot afford it under EPAP (Eliven Patient Assistance Program).

Orion pharma is dedicated to serve its valued customers with products of excellent quality through continuous improvement in technology, process and human resources complying with the guidelines of Good Manufacturing Practice (GMP) and the requirements of ISO-9001: 2000 Quality Management System (QMS).

Thursday, 10 January 2013

Obaidul Karim: Development Is My Goal

Obaidul Karim is a Bangladeshi businessman and industrialist known for his involvement with Orion Group, a large diversified industrial conglomerate headquartered in Dhaka, Bangladesh.

ICB Capital Management Ltd (ICML) agreed to be the issue manager of Orion Group Laboratories, a subsidiary of Orion Group, for issuing an IPO under book-building method. Mohammad Obaidul Karim, managing director of Orion Group Laboratories, and Mohammad Abdur Rauf, chief executive officer of ICML, signed the agreement in Dhaka.

Orion Group Laboratories has recently signed an issue management agreement with state-owned ICB Capital Management Ltd (ICML) for issuing initial public offering (IPO) through book-building method, said a statement.

ICML will work as an issue manager of Orion Group Laboratories, a subsidiary of Orion Group.Obaidul Karim, managing director of Orion Laboratories, and Abdur Rauf, chief executive officer of ICML, signed the deal on behalf of their respective organisations on Monday.

Orion Laboratories will collect the money from the general investors to set up a pharmaceutical plant and a power plant.This new factory will be the biggest in the pharmaceutical industry in Bangladesh in terms of investment, covered area, and the number of varieties of dosage forms to be produced, said the statement.
The 200 MW power plant under the purview of Orion Laboratories will be added to the national grid by March next year, the statement added.

Friday, 16 November 2012

Orion signs issue manager deal

ICB Capital Management Ltd (ICML) agreed to be the issue manager of Orion Group Laboratories, a subsidiary of Orion Group, for issuing an IPO under book-building method. Mohammad Obaidul Karim, managing director of Orion Group Laboratories, and Mohammad Abdur Rauf, chief executive officer of ICML, signed the agreement in Dhaka on Monday.

Orion Group

Orion Group Laboratories has recently signed an issue management agreement with state-owned ICB Capital Management Ltd (ICML) for issuing initial public offering (IPO) through book-building method, said a statement.
ICML will work as an issue manager of Orion Group Laboratories, a subsidiary of Orion Group.
Obaidul Karim, managing director of Orion Laboratories, and Abdur Rauf, chief executive officer of ICML, signed the deal on behalf of their respective organisations on Monday.
Orion Laboratories will collect the money from the general investors to set up a pharmaceutical plant and a power plant.
This new factory will be the biggest in the pharmaceutical industry in Bangladesh in terms of investment, covered area, and the number of varieties of dosage forms to be produced, said the statement.
The 200MW power plant under the
purview of Orion Laboratories will be added to the national grid by March next year, the statement added.
More About Obaidul karim.........

Friday, 9 November 2012

Obaidul Karim Owner Of orion group

orion group

The government has entered a deal with Orion Group to install three private coal-based power plants to add 1088MW power to the national grid.
Although there is a government-run coal-based power plant producing 250MW power at Barapukuria, this is the first move to get private firms to produce power from coal.
On Jan 29, the government struck a deal with India for installing a coal-based power plant with a capacity to produce 1030MW at Rampal in Bagherhat near the Sundarbans.
One of the new power plants will be set up at Mawa in Munsiganj to produce 522MW. Two other plants will be established at Anwara in Chittagong and in Khulna each with a capacity of generating 282.67MW.
Orion Group Managing Director Salman Obaidul Karim and Power Development Board (PDB) Secretary Md Azizul Islam signed the agreement at the Bidyut Bhaban.
The power plant at Mawa will go into operation in 45 months while the plants at Khulna and Chittagong will be built in 36 months.
The government will pay Tk 4.79 for per unit power produced by the Mawa plant and Tk 4.45 for power supplied from the other two plants.
Currently daily power production is 5,500MW against the demand of 7,000MW.
The Prime Minister's Adviser Tawfiq-e-Elahi Chowdhury, State Minister for Power Mohammad Enamul Hoque, Power Secretary Abul Kalam Azad, PDB Chairman ASM Alamgir Kabir and Orion Group Chairman Obaidul Karim were present at the ceremony.
"Many had feared whether it would be possible at all to establish power plant by importing coal. After overcoming all the challenges we are going to prove that through this agreement. I hope the plants will come into operation at the expected time," said advisor Chowdhury.
Chairman Karim said they will import coal from Australia and Indonesia and that reputed organisations have been employed to look into issues including building the plants and importing coal.
He was also hopeful about making the plants operational three months before schedule.
Power is being produced using five types of energy. About 80 percent of the daily power is being produced using gas, while furnace oil and diesel are used for producing 17 percent. Water and coal produces 3 percent.
After assuming power the government undertook a plan of raising daily power production by 15,000MW within 2016.

Wednesday, 7 November 2012

Orion Group win SCDI Award - Outstanding Business Achievement

Orion Group Scotland's biggest manpower provider has scooped the coveted SCDI Highland and Islands Chairman Award for Outstanding Business Achievement at a ceremony at the Drumossie Hotel, Inverness on Friday 14 Sep.
Orion Group has had 25 successful years and totalled record sales of £317m during 2011. The Group is continually striving to be the best in the world and this year Orion will see an increase of £60m in sales in 2011.
Michael Urquhart, SCDI Highlands & Islands Chairman said:
“Orion Group celebrates its 25th birthday this year and given their contribution to the community and commitment to the Highlands they are rightfully receiving this recognition.
"With 128 staff employed at their Inverness base, 259 deployed around the world and over 4,000 contractors working through the Group at any one time, Orion plays an important role in the Highland economy.
"Alan Savage's drive, determination and commitment to his company saw it achieve record sales of £317m last year and I have no doubt that they will continue to grow from strength to strength."
Commenting on their success Alan Savage, Chairman of Orion Group added:
"I am delighted that Orion have received the SCDI Chairman's Award for Outstanding Business Achievement, recognising the dedication and skills of our staff both in Inverness and around the world.
"When I started Orion 25 years ago I had never thought that it would become the success it is today and I am honoured to receive this recognition on behalf of all those who have worked to make Orion what it is today."
Alan continued, "2012 is proving to be a bumper year for Orion Group. We're currently in the throes of enjoying our 25th Anniversary and now we get to add this SCDI Award to our reasons to celebrate."f

Obaidul karim Owner Of Orion Group